Founded in 1998, MicroDose Therapeutx, formerly Microdose Technologies, Inc., is a specialty pharmaceutical company successfully pioneering the creation of next-generation products utilizing its proprietary drug delivery technologies. In the pipeline, its Dry Powder Inhaler, PolyCap™ systems, and Needlefree technologies promise to dramatically improve efficacy and compliance. MicroDose’s exceptional, multi-disciplinary team and partners are dedicated to delivering these innovative products to help transform the lives of patients suffering from a wide range of debilitating diseases including asthma, COPD, diabetes, and hypertension.